Web only References
w1. Collins JS, Hamilton PW, Watt PC, et al. Superficial gastritis and Campylobacter pylori in dyspeptic patients--a quantitative study using computer-linked image analysis. J Pathol 1989;158:303-310.
w2. Deltenre M, Nyst JF, Jonas C, et al. Clinical, endoscopic and histologic findings in 1,100 patients of whom 574 were colonized by Campylobacter pylori. Gastroenterol Clin Biol 1989;13:89B-95B.
w3. Dooley CP, Arandia D, Dehesa M, et al. An evaluation of the role of Helicobacter pylori infection in nonulcer dyspepsia. Gastroenterology 1990;98:A37.
w4. Guitiérrez O, Sierra F, Gomez MC, et al. Campylobacter pylori in chronic environmental gastritis and duodenal ulcer patients. Gastroenterology 1988;94:A163.
w5. Guitiérrez O, Gomez MC, Ricaurte O, et al. Relation between Helicobacter pylori, gastric histology, and dyspepsia in general population. Gastroenterology 1999;116:G0779.
w6. Kang G, Rajan DP, Patra S, et al. Use of serology, the urease test & histology in diagnosis of Helicobacter pylori infection in symptomatic & asymptomatic Indians. Indian J Med Res 1999;110:86-90.
w7. Katelaris PH, Tippett GH, Norbu P, et al. Dyspepsia, Helicobacter pylori, and peptic ulcer in a randomly selected population in India. Gut 1992;33:1462-1466.
w8. Pereira-Lima JG, Scholl J, Pinheiro JB, et al. Helicobacter pylori-associated gastritis: does it play a role in functional dyspepsia? Z.Gastroenterol. 1995;33:421-425.
w9. Pospai D, Farahat K, Vissuzaine C, et al. Duodenal Hp: its prevalence and determinants in dyspeptic patients and in controls. Gut 1997;41 Suppl 3:A108.
w10. Prasad S, Mathan M, Chandy G, et al. Prevalence of Helicobacter pylori in southern Indian controls and patients with gastroduodenal disease. J Gastroenterol Hepatol 1994;9:501-506.
w11. Rauws EA, Langenberg W, Houthoff HJ, et al. Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 1988;94:33-40.
w12. Rokkas T, Pursey C, Uzoechina E, et al. Campylobacter pylori and non-ulcer dyspepsia. Am J Gastroenterol 1987;82:1149-1152.
w13. Singh V, Trikha B, Nain CK, et al. Epidemiology of Helicobacter pylori and peptic ulcer in India. Gastroenterology 1999;116:G0412
w14. Strauss RM, Wang TC, Kelsey PB, et al. Association of Helicobacter pylori infection with dyspeptic symptoms in patients undergoing gastroduodenoscopy. Am J Med 1990;89:464-469.
w15. Trespi E, Broglia F, Villani L, et al. Distinct profiles of gastritis in dyspepsia subgroups. Their different clinical responses to gastritis healing after Helicobacter pylori eradication. Scand J Gastroenterol 1994;29:884-888.
w16. Tsega E, Gebre W, Manley P, et al. Helicobacter pylori, gastritis and non-ulcer dyspepsia in Ethiopian patients. Ethiop Med J. 1996;34:65-71.
w17. Tucci A, Corinaldesi R, Stanghellini V, et al. Helicobacter pylori infection and gastric function in patients with chronic idiopathic dyspepsia. Gastroenterology 1992;103:768-774.
w18. Uyub AM, Raj SM, Visvanathan R, et al. Helicobacter pylori infection in north-eastern peninsular Malaysia. Evidence for an unusually low prevalence. Scand J Gastroenterol 1994;29:209-213.
w19. Agreus L, Engstrand L, Svardsudd K, et al. Helicobacter pylori seropositivity among Swedish adults with and without abdominal symptoms. A population-based epidemiologic study. Scand J Gastroenterol 1995;30:752-757.
w20. Bazzoli F, Zagari RM, Festi D, et al. A population based study of Helicobacter pylori infection. II: Prevalence by 13 C-urea breath test and association with dyspeptic symptoms. Gut 1997;41 Suppl 3:A106
w21. Braden B, Caspary WF, Lembcke B. Density of gastric Helicobacter pylori colonization is not associated with occurrence of dyspeptic symptoms. Dig.Dis.Sci. 1997;42:2120-2123. study.
w22. Holcombe C, Omotara BA, Eldridge J, et al. H. pylori, the most common bacterial infection in Africa: a random serological study. Am J Gastroenterol 1992;87:28-30.
w23. Woodward M, Morrison CE, McColl KE. The prevalence of dyspepsia and use of antisecretory medication in North Glasgow: role of Helicobacter pylori vs. lifestyle factors. Aliment Pharmacol Ther 1999;13:1505-1509.
w24. Ani AE, Malu AO, Queiroz DM, et al. Determination of IgG antibodies against Helicobacter pylori in adult dyspeptic patients and blood donors from Jos, Nigeria. Med Sci Res 1998;26:689-690.
w25. Glasbrenner B, Malfertheiner P, Nilius M, et al. Prevalence of Helicobacter pylori infection and dyspepsia in young adults in Germany. Z.Gastroenterol. 1996;34:478-482.
w26. Holcombe C, Kaluba J, Lucas SB. Non-ulcer dyspepsia in Nigeria: a case-control study. Trans R Soc Trop Med Hyg 1991;85:553-555.
w27. Holtmann G, Goebell H, Holtmann M, et al. Dyspepsia in healthy blood donors. Pattern of symptoms and association with Helicobacter pylori. Dig Dis Sci 1994;39:1090-1098.
w28. Holtmann G, Talley NJ, Mitchell H, et al. Antibody response to specific H. pylori antigens in functional dyspepsia, duodenal ulcer disease, and health. Am J Gastroenterol 1998;93:1222-1227.
w29. Nandurkar S, Talley NJ, Xia H, et al. Dyspepsia in the community is linked to smoking and aspirin use but not to Helicobacter pylori infection. Arch Intern Med 1998;158:1427-1433.
w30. Nelson DB, Murdoch M, Sandozi IF, et al. Dyspepsia in the community is associated with cagA positive Helicobacter pylori. Gastroenterology 1999;116:G1160
w31. Parsonnet J, Blaser MJ, Perez-Perez GI, et al. Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology 1992;102:41-46.
w32. Olmos JA, Higa R, Rios H, et al. Association between subjects with dyspeptic symptoms and Helicobacter pylori: Epidemiologic study conducted in 16 centres in Argentina. Gastroenterology 1998;114:A248
w33. Schilling D, Schauwecker P, Eberle F, et al. The pathogenic role of Helicobacter pylori (HP) infection in non-ulcer dyspepsia (NUD): A cross-sectional, evaluation of 6143 active employees in a large company. Gastroenterology 1998;114:A279
w34. Schlemper RJ, van der Werf SD, Biemond I, et al. Dyspepsia and Helicobacter pylori in Japanese employees with and without ulcer history. J Gastroenterol Hepatol 1995;10:633-638.
w35. Verdu EF, Fraser R, Tiberio D, et al. Prevalence of Helicobacter pylori infection and chronic dyspeptic symptoms among immigrants from developing countries and people born in industrialized countries. Digestion 1996;57:180-185.
w36. Brulley des Varannes S, Flejou JF, Colin R, et al. Helicobacter pylori (Hp) eradication in non-ulcer dyspepsia (NUD): A randomized, double-blind, placebo- controlled study with 12-month follow-up. Gastroenterology 2000;118:2545
w37. Froehlich F, Gonvers JJ, Wietlisbach V, et al. Helicobacter pylori eradication treatment does NOT benefit patients with non-ulcer dyspepsia. Gastroenterology 2000;118:2553
w38. Koelz HR, Arnold R, Stolte M, et al. Treatment of Helicobacter pylori does not improve symptoms of functional dyspepsia. Gastroenterology 1998;114:A182
w39. Miwa H, Hirai S, Nagahara A, et al. Cure of Helicobacter pylori infection does not improve symptoms in non- ulcer dyspepsia patients - a double-blind placebo-controlled study. Aliment Pharmacol Ther 2000;14:317-324.
w40. Passos MCF, Coelho LGV, Gloria ALF, et al. Helicobacter pylori eradication for functional dyspepsia: A long-term, randomized, prospective, double-blind, placebo- controlled study. Gut 1998;43 Suppl 2:A81
w41. Dhali GK, Garg PK, Sharma MP. Role of anti-Helicobacter pylori treatment in H. pylori-positive and cytoprotective drugs in H. pylori-negative, non-ulcer dyspepsia: results of a randomized, double-blind, controlled trial in Asian Indians. J Gastroenterol Hepatol 1999;14:523-528.
w42. Frazzoni M, Lonardo A, Grisendi A, et al. Are routine duodenal and antral biopsies useful in the management of "functional" dyspepsia? A diagnostic and therapeutic study. J Clin Gastroenterol 1993;17:101-108.
w43. Goh KL, Parasakthi N, Peh SC, et al. Helicobacter pylori infection and non-ulcer dyspepsia: the effect of treatment with colloidal bismuth subcitrate. Scand J Gastroenterol 1991;26:1123-1131.
w44. Holcombe C, Thom C, Kaluba J, et al. Helicobacter pylori clearance in the treatment of non-ulcer dyspepsia. Aliment Pharmacol Ther 1992;6:119-123.
w45. Kang JY, Tay HH, Wee A, et al. Effect of colloidal bismuth subcitrate on symptoms and gastric histology in non-ulcer dyspepsia. A double blind placebo controlled study. Gut 1990;31:476-480.
w46. Kazi JI, Jafarey NA, Alam SM, et al. A placebo controlled trial of bismuth salicylate in Helicobacter pylori associated gastritis. JPMAJ Pak Med Assoc 1990;40:154-156.
w47. Lambert JR, Dunn K, Borromeo M, et al. Campylobacter pylori--a role in non-ulcer dyspepsia? Scand J Gastroenterol Suppl 1989;160:7-13.
w48. Loffeld RJ, Potters HV, Stobberingh E, et al. Campylobacter associated gastritis in patients with non-ulcer dyspepsia: a double blind placebo controlled trial with colloidal bismuth subcitrate. Gut 1989;30:1206-1212.
w49. McNulty CA, Gearty JC, Crump B, et al. Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate. Br Med J 1986;293:645-649.
w50. Rokkas T, Pursey C, Uzoechina E, et al. Non-ulcer dyspepsia and short term De-Nol therapy: a placebo controlled trial with particular reference to the role of Campylobacter pylori. Gut 1988;29:1386-1391.
w51. Vaira D, Holton J, Ainley C, et al. Double blind trial of colloidal bismuth subcitrate versus placebo in Helicobacter pylori positive patients with non-ulcer dyspepsia. Ital J Gastroenterol 1992;24:400-404.